乳房切除术后重建中脂肪移植对乳腺影像学检查的影响:匹配队列分析
该匹配队列分析纳入2010至2018年乳房切除术后自体重建或假体重建患者186例,按BMI、重建时机和重建类型1:1倾向匹配为93对。脂肪移植组可触及肿块和重建后影像检查发生率更高,但活检数量无显著差异,影像多为正常或良性,脂肪坏死最常见,且脂肪移植未降低5年总生存或无局部区域复发生存。
要点
- 脂肪移植增加可触及肿块和重建后影像检查,但活检无显著增加。
- 影像多为正常或良性,脂肪坏死是最常见发现。
- 脂肪移植未降低5年总生存或无局部区域复发生存。
核心结论
- 脂肪移植与可触及肿块和重建后影像检查增加相关,影像学发现为良性。
- 该操作肿瘤学安全,但患者和医生应知晓其良性后遗症可能增加影像检查。
研究设计与样本
- 回顾性匹配队列分析,纳入2010至2018年乳房切除术后自体重建或假体重建患者186例,1:1倾向匹配为93对,协变量为BMI、重建时机和重建类型。
主要发现
- 脂肪移植组可触及肿块发生率38.0% vs 18.3%(p=0.003)。
- 脂肪移植组重建后影像检查发生率47.3% vs 29.0%(p=0.01)。
- 活检数量无显著差异(11.8% vs 7.5%,p=0.32)。
- 影像主要判读为正常(BI-RADS 1,27.9%)或良性(BI-RADS 2,48.8%),脂肪坏死最常见[n=20(45.5%)]。
- 多因素分析中无人口学、肿瘤学、重建或脂肪移植特异性变量可预测重建后影像检查;脂肪移植未与5年总生存或无局部区域复发生存降低相关。
关键数值与推荐
- 脂肪移植组可触及肿块38.0% vs 18.3%(p=0.003)。
- 脂肪移植组重建后影像检查47.3% vs 29.0%(p=0.01)。
- 活检数量11.8% vs 7.5%(p=0.32),无显著差异。
- 影像判读BI-RADS 1占27.9%,BI-RADS 2占48.8%,脂肪坏死n=20(45.5%)。
临床怎么用
- 脂肪移植后出现的可触及肿块常为良性后遗症,应结合影像学评估,避免不必要的活检。
- 向患者告知脂肪移植可能增加影像检查频率,但肿瘤学安全性未受影响。
局限性
- 证据等级为治疗性III级。
- 样本量186例,匹配后93对,可能限制统计效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fat grafting to the reconstructed breast may result in the development of benign lesions on physical examination, prompting further investigation with imaging and biopsy. The aim of this study was to assess the influence of fat grafting on the incidence of imaging and biopsies after postmastectomy reconstruction. METHODS: Patients who underwent autologous or implant-based reconstruction following mastectomy from 2010 to 2018 were identified. Those receiving fat grafting as part of their reconstructive course were propensity matched 1:1 to those that did not with body mass index, reconstruction timing, and reconstruction type as covariates in a multivariable logistic regression model. RESULTS: A total of 186 patients were identified, yielding 93 propensity-matched pairs. Fat-grafted patients had higher incidences of palpable masses (38.0 percent versus 18.3 percent; p = 0.003) and postreconstruction imaging (47.3 percent versus 29.0 percent; p = 0.01), but no significant difference in the number of biopsies performed (11.8 percent versus 7.5 percent; p = 0.32). Imaging was predominately interpreted as normal (Breast Imaging-Reporting and Data System 1, 27.9 percent) or benign (Breast Imaging-Reporting and Data System 2, 48.8 percent), with fat necrosis being the most common finding [n = 20 (45.5 percent)]. No demographic, oncologic, reconstructive, or fat grafting-specific variables were predictive of receiving postreconstruction imaging on multivariate analysis. Fat grafting was not associated with decreased 5-year overall survival or locoregional recurrence-free survival. CONCLUSIONS: Fat grafting to the reconstructed breast is associated with increased incidences of palpable masses and subsequent postreconstruction imaging with benign radiographic findings. Although the procedure is oncologically safe, both patients and providers should be aware that concerning physical examination findings can be benign sequelae of fat grafting and may lead to increased imaging after breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Cason RW, Shammas RL, Broadwater G, et al. The Influence of Fat Grafting on Breast Imaging after Postmastectomy Reconstruction: A Matched Cohort Analysis. Plast Reconstr Surg. 2020. PMID: 33234948. doi:10.1097/PRS.0000000000007327
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。